GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of FATE
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for Fate Therapeutics stock after losing 4.36%
(Updated on Apr 18, 2024)

Sell candidate since Apr 09, 2024 Loss -25.44% PDF

The Fate Therapeutics stock price fell by -4.36% on the last day (Thursday, 18th Apr 2024) from $5.27 to $5.04. It has now fallen 7 days in a row. During the last trading day the stock fluctuated 7.33% from a day low at $4.98 to a day high of $5.35. The price has fallen in 9 of the last 10 days and is down by -27.69% for this period. Volume has increased on the last day by 248 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $11.74 million.

Given the current short-term trend, the stock is expected to rise 13.13% during the next 3 months and, with a 90% probability hold a price between $5.70 and $9.99 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

FATE Signals & Forecast

There are few to no technical positive signals at the moment. The Fate Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.62 and $6.93. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, March 07, 2024, and so far it has fallen -39.64%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Fate Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $4.72 and $4.56. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Fate Therapeutics finds support just below today's level at $4.72. If this is broken, then the next support from accumulated volume will be at $4.56 and $4.53.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.365 between high and low, or 7.33%. For the last week, the stock has had daily average volatility of 7.72%.

Fate Therapeutics is oversold on RSI14 (9). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (FATE) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Fate Therapeutics to open at $5.12, and during the day (based on 14 day Average True Range), to move between $4.54 and $5.54, which gives a possible trading interval of +/-$0.505 (+/-10.01%) up or down from last closing price. If Fate Therapeutics takes out the full calculated possible swing range there will be an estimated 20.02% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.72 (6.35%) than the resistance at $5.72 (13.49%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Fate Therapeutics stock A Buy?

The Fate Therapeutics stock holds several negative signals and despite the positive trend, we believe Fate Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.753 Sell Candidate Unchanged

Predicted Opening Price for Fate Therapeutics of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$5.12 ( 1.62%) $5.04

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for FATE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.49 8.86 %
R2 5.35 6.10 %
R1 5.26 4.39 %
Current price: 5.04
Support S1 4.98 -1.15 %
S2 4.90 -2.86 %
S3 4.76 -5.62 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 6.16 22.22 %
R2 5.74 13.89 %
R1 5.72 13.49 %
Current price 5.04
Support S1 4.72 -6.35%
S2 4.56 -9.52%
S3 4.53 -10.12%

FAQ

What is the symbol for Fate Therapeutics Stock and on which exchange is it traded?
The symbol for Fate Therapeutics is FATE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Fate Therapeutics Stock?
The Fate Therapeutics stock holds several negative signals and despite the positive trend, we believe Fate Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Fate Therapeutics Stock?
Fate Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Fate Therapeutics Stock.

What's the current price of Fate Therapeutics Stock?
As of the end of day on the 2024-04-18, the price of an Fate Therapeutics (FATE) share was $5.04.

What is the 52-week high and low for Fate Therapeutics Stock?
The 52-week high for Fate Therapeutics Stock is $8.83 and the 52-week low is $1.63.

What is the market capitalization of Fate Therapeutics Stock?
As of the 2024-04-18, the market capitalization of Fate Therapeutics is 522.982M.

When is the next earnings date for Fate Therapeutics?
The upcoming earnings date for Fate Therapeutics is May 01, 2024.
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT